Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);血管成形术, 气囊, 冠状动脉(Angioplasty, Balloon, Coronary);抗体, 单克隆(Antibodies, Monoclonal);综合疗法(Combined Modality Therapy);冠状动脉再狭窄(Coronary Restenosis);无病生存(Disease-Free Survival);药物释放系统(Drug Delivery Systems);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);免疫球蛋白Fab片段(Immunoglobulin Fab Fragments);男(雄)性(Male);中年人(Middle Aged);心肌梗死(Myocardial Infarction);血小板聚集抑制剂(Platelet Aggregation Inhibitors);血小板糖蛋白GPⅡb-Ⅲa复合物(Platelet Glycoprotein GPIIb-IIIa Complex);比例危险度模型(Proportional Hazards Models);假体设计(Prosthesis Design);危险(Risk);西罗莫司(Sirolimus);支架(Stents);酪氨酸(Tyrosine)
DOI
10.1016/j.jacc.2007.04.029
PMID
17616297
发布时间
2018-12-01
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文